United States

Comment Letter

Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice

The FasterCures team at the Milken Institute is honored to provide its response to the Request for Comments on Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice [Docket No. FDA-2024-D...
Read Letter
Portrait of Esther Krofah

Esther Krofah

Executive Vice President, Milken Institute Health
Esther Krofah is the executive vice president of Health at the Milken Institute, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. A recognized expert in health policy, biomedical innovation, and clinical research, Krofah has extensive experience shaping health initiatives that unite diverse stakeholders, foster collaboration, and motivate action toward shared goals.
Kevin Klowden participating in the forum “AI: Angel or Demon” hosted by the ID Foros series in Bogotá, Colombia.
Insights

The AI Challenge Is About More Than Just a Race Between the US and China

The race to develop a global edge in artificial intelligence continues to grip the imagination of reporters, investors, financiers, and policymakers worldwide. For leaders in the United States and China in particular, the ability of their...
Read Article
Portrait of Kevin Klowden

Kevin Klowden

Senior Fellow, Milken Institute Finance
Kevin Klowden is a senior fellow at Milken Institute Finance. He specializes in the study of key factors that underlie the development of competitive regional economies (clusters of innovation, patterns of trade and investment, and concentration of skilled labor) and how these are influenced by public policy and, in turn, affect regional economies both globally and nationally.
Subscribe to United States